Xtampza er and Olanzapine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xtampza er (oxycodone) and Olanzapine (olanzapine). Common drug interactions include hypokalaemia among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Xtampza er and Olanzapine. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Xtampza er?

Xtampza er has active ingredients of oxycodone. eHealthMe is studying from 1,502 Xtampza er users. Check the latest studies of Xtampza er.

What is Olanzapine?

Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 69,242 Olanzapine users. Check the latest studies of Olanzapine.

On Jul, 17, 2026

13 people who take Xtampza er and Olanzapine together, and have interactions are studied.

Xtampza er and Olanzapine drug interactions.

What are the common drug interactions of Xtampza Er and Olanzapine, by gender? *:

female:

Hypokalaemia (low potassium)
Osteoporosis (bones weak and more likely to break)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Constipation

male:

Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Nasopharyngitis (inflammation of the nasopharynx)
White blood cell count decreased
Anxiety
Death
Drug ineffective

What are the common drug interactions of Xtampza Er and Olanzapine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Drug ineffective

60+:

Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Nasopharyngitis (inflammation of the nasopharynx)
White blood cell count decreased
Anxiety
Death
Hypokalaemia (low potassium)

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 5 people, 38.46%
Multiple Myeloma (cancer of the plasma cells): 4 people, 30.77%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 7.69%
Stress And Anxiety: 1 person, 7.69%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.69%
Pain: 1 person, 7.69%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 7.69%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 7.69%
Dyspnea (difficult or laboured breathing): 1 person, 7.69%
Depression: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Xtampza er and Olanzapine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously